LACTIC ACID BACTERIA AND THEIR USE FOR THE TREATMENT OF MASTITIS

USPTO Patent Application US 2018/0273895 A1
Application Date: Sep. 27th, 2018

ABSTRACT

The present invention relates to novel Lactic Acid Bacteria strains Lactobacillus reuteri selected from the group comprising Lactobacillus reuteri DSM 32229, Lactobacillus reuteri DSM 32230, Lactobacillus reuteri DSM 32231 and...
Application Number:
15/543,974
International Classification:
C12N 1/20 (20060101); C12R 1/225 (20060101); A61K 35/747 (20060101); A61K 9/00 (20060101); C12Q 1/6883 (20060101)
No Pictures Available

CLAIMS

What is claimed is:

1. A biologically pure culture of Lactobacillus reuteri selected from the Lactobacillus reuteri DSM 32229, Lactobacillus reuteri DSM 32230, Lactobacillus reuteri DSM 32231, and Lactobacillus reuteri DSM 32232, in a dried form.

DESCRIPTION

This application is a national phase entry pursuant to 35 U.S.C. § 371 of International Application No. PCT/EP2016/050699, filed Jan. 14, 2016, which claims the benefit of U.S. Provisional Application No. 62/104,164, filed Jan. 16, 2015, each of which is incorporated by reference herein in its entirety for any purpose.
Back to Top